Case Studies
LIFESCI ACTIVITIES: Transparency and Communication: LifeSci helped Crinetics to determine appropriate expectations, craft messaging around those expectations, and carry through with them. Investor Education: LifeSci helped create a clear investor targeting strategy that optimized the management team’s time and resources. The strategy required selectivity and prioritization to avoid fatigue, as apposed to adopting an “any…
Read More
BACKGROUND LifeSci embarked on a journey with Ambrx, beginning in November 2022, with a shared vision of enhancing its market presence and investor relations landscape. Over the course of this partnership, LifeSci’s approach was multifaceted, aiming not just to amplify Ambrx’s visibility, but to weave a narrative that resonated deeply with investors and stakeholders alike.…
Read More
BACKGROUND Vyne Therapeutics engaged LifeSci Advisors in a strategic partnership to elevate its presence among global investors since 2014. LIFESCI’S ACTIVITIES • Thorough market research, including landscape analysis & peer company reviews, was conducted to refine VYNE’s equity narrative. This involved assessing clinical development timelines, data curves, and market opportunities to better align with investor…
Read More
BACKGROUND Verrica Pharmaceuticals has been a LifeSci client since December 2022. As part of the strategy to raise the Company’s visibility amongst global investors, LifeSci scheduled multiple Non-Deal Roadshows with top-tier institutions as well as organized and hosted an in-person High-Net-Worth and family-office investor event for Verrica in New York City. The event created a…
Read More
LifeSci has worked extensively with Abivax since 2015 to optimize and improve company positioning to actively increase visibility amongst investors and strategics internationally. With iterative updates to company materials, LifeSci strives to provide in depth updates and reviews of all internal and external content. LIFESCI’s ACTIVITIES Strengthened Abivax’s position globally as a leader in the…
Read More
BACKGROUND Femasys Inc. has been a LifeSci client since July 2021. As part of a strategy to raise the Company’s visibility amongst global investors, LifeSci organized and hosted an in-person High-Net-Worth and family-office investor event for Femasys in New York City. The event created a great opportunity for Femasys to showcase its first-in-class technologies in…
Read More
enVVeno Medical Corporation became a LifeSci Advisors client in 2021. The teams collaborated to develop and execute a robust, best-in-class investor relations program to engage the investment community and showcase enVVenos developments. PROCESS This event featured a live virtual presentation featuring two principal investigators from the ongoing VenoValve U.S. pivotal trial: Dr. David Dexter, Sentara…
Read More
InspireMD successfully completed a transformational Private Placement for up to $113.6 million, with $42.2 million financing upfront with up to an additional $71.4 million tied to exercise of milestone-driven warrants. LIFESCI’s ACTIVITIES Continuous efforts to strengthen company relationships with relevant sell-side analysts to improve research coverage through leveraging existing relationships and making new introductions to…
Read More
LifeSci have worked extensively over the years to raise the Company’s visibility amongst investors and strategics, preparing the market for their positive data read out and ultimately leading to a successful acquisition. LIFESCI’s ACTIVITIES Strengthen Amryt’s position as a global leader in rare and orphan diseases through strategic corporate communications following the acquisition of Chiasma…
Read More
Orchestra BioMed’s partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products it develops. LIFESCI’s ACTIVITIES LifeSci engaged following a global strategic partnership with Terumo announced in June 2019 Strengthen the equity story and position the Company to secure additional strategic global partnerships Raise visibility…
Read More